Pdt Partners, LLC Corcept Therapeutics Inc Transaction History

Pdt Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$17.33 - $25.3 $449,973 - $656,914	-25,965 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$16.53 - $25.21 $7,636 - $11,647	-462 Reduced 1.75%	25,965 $585,000
Q4 2021 Feb 14, 2022	BUY	$17.1 - $23.34 $268,316 - $366,227	15,691 Added 146.15%	26,427 $523,000
Q3 2021 Nov 15, 2021	BUY	$19.68 - $22.53 $211,284 - $241,882	10,736 New	10,736 $211,000
Q1 2020 May 15, 2020	SELL	$10.11 - $14.04 $220,398 - $306,072	-21,800 Closed	0 $0

Q4 2019 Feb 14, 2020	BUY	$12.06 - $16.96 $262,908 - $369,728	21,800 New	21,800 $264,000

314

93.8M

2.02M

3.24M

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $3.48B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.